Prescription of Sedative Drugs During Hospital Stay: A Swiss Prospective Study
Tóm tắt
In recent years, the number of prescriptions for sedative drugs has increased significantly, as has their long-term use. Moreover, sedative use is frequently initiated during hospital stays. This study aimed to describe new prescriptions of sedative drugs during hospital stays and evaluate their maintenance as discharge medication. This observational prospective study took place in an internal medicine ward of a Swiss hospital over a period of 3 months in 2014. Demographic (age, sex, diagnosis, comorbidities) and medication data [long-term use of sedative drugs, new regular or pro re nata (‘as needed’) prescriptions of sedative drugs, drug-related problems] were collected. Sedative medications included: benzodiazepines, Z-drugs, antihistamines, antidepressants, neuroleptics, herbal drugs, and clomethiazole. McNemar’s test was used for comparison. Of 290 patients included, 212 (73%) were over 65 years old and 169 (58%) were women; 34% (n = 98) were using sedative drugs long term before their hospital stay, and 44% (n = 128) had a prescription for sedative drugs at discharge—a 10% increase (p < 0.05). Sedative drugs were newly prescribed to 37% (n = 108) of patients during their stay. Among these, 37% (n = 40) received a repeat prescription at discharge. Over half of the sedative drugs were prescribed within 24 h of admission. Drug-related problems were detected in 76% of new prescriptions, of which 90% were drug–drug interactions. This study showed that hospital stays increased the proportion of patients who were prescribed a sedative drug at discharge by 10% (absolute increase). These prescriptions may generate long-term use and expose patients to drug-related problems. Promoting alternative approaches for managing insomnia are recommended.
Tài liệu tham khảo
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.
Rogev E, Pillar G. Placebo for a single night improves sleep in patients with objective insomnia. Israel Med Assoc J. 2013;15(8):434–8.
Moloney ME, Konrad TR, Zimmer CR. The medicalization of sleeplessness: a public health concern. Am J Public Health. 2011;101(8):1429–33. doi:10.2105/AJPH.2010.300014.
Suchtmonitoring. Continuous Rolling Survey on Addictive Behaviours and Related Risks (CoRolAR). 2012. http://www.suchtmonitoring.ch/fr/6.html?somniferes-et-tranquillisants. Accessed 9 Sept 2017.
Société Vaudoise de Médecine MdfV, Pharmaciens vaudois. Etat de Vaud. Campagne de Prévention: Somnifères? Pas forcément nécessaires! 2013. http://www.vd.ch/index.php?id=53571. Accessed 19 Feb 2015.
Frighetto L, Marra C, Bandali S, Wilbur K, Naumann T, Jewesson P. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients. Health Qual Life Outcomes. 2004;2:17. doi:10.1186/1477-7525-2-17.
Swiss drugs database 2014–2015. 2015. http://www.swissmedicinfo.ch/. Accessed 9 Sep 2017.
Drugs’ database with drug–drug-interaction data. 2014. http://www.uptodate.com/crlsql/interact/frameset.jsp. Accessed 9 Sep 2017.
Johnson CF, Frei C, Downes N, McTaggart SA, Akram G. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract. 2016;66(647):e410–5. doi:10.3399/bjgp16X685213.
Woodward MCCS, Elliott R, Vernon G, Tanner F, Saunders R. Managing insomnia in older people. J Pharm Pract Res. 2007;37(3):236–41.
Belknap SM. In adults, use of anxiolytic or hypnotic drugs was associated with increased risk for mortality. Ann Intern Med. 2014;161(2):JC11. doi:10.7326/0003-4819-161-2-201407150-02011.
Amarasuriya UK, Myles PR, Sanders RD. Long-term benzodiazepine use and mortality: are we doing the right studies? Curr Drug Saf. 2012;7(5):367–71.
Salonoja M, Salminen M, Aarnio P, Vahlberg T, Kivela SL. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing. 2010;39(3):313–9. doi:10.1093/ageing/afp255.
Isaia G, Corsinovi L, Bo M, Santos-Pereira P, Michelis G, Aimonino N, et al. Insomnia among hospitalized elderly patients: prevalence, clinical characteristics and risk factors. Arch Gerontol Geriatr. 2011;52(2):133–7. doi:10.1016/j.archger.2010.03.001.
Nagel CL, Markie MB, Richards KC, Taylor JL. Sleep promotion in hospitalized elders. Medsurg Nurs. 2003;12(5):279–89 (quiz 90).
Warie H, Petrovic M, Somers A, Mariman A, Robays H, Pevernagie D. The use of hypnosedative drugs in a university hospital setting. Acta Clin Belg. 2003;58(4):225–32. doi:10.1179/acb.2003.58.4.003.
Cunnington D, Junge MF, Fernando AT. Insomnia: prevalence, consequences and effective treatment. Med J Aust. 2013;199(8):S36–40.
Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health. 2000;24(1):7–10.
Tu K, Mamdani MM, Hux JE, Tu JB. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49(10):1341–5.
Voyer P, Preville M, Cohen D, Berbiche D, Beland SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29(2):205–13. doi:10.1017/s0714980810000115.
Elliott RA, Woodward MC, Oborne CA. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Int Med J. 2001;31(9):529–35.
Cumbler E, Guerrasio J, Kim J, Glasheen J. Use of medications for insomnia in the hospitalized geriatric population. J Am Geriatr Soc. 2008;56(3):579–81. doi:10.1111/j.1532-5415.2008.01598.x.
Somers A, Robays H, Audenaert K, Van Maele G, Bogaert M, Petrovic M. The use of hypnosedative drugs in a university hospital: has anything changed in 10 years? Eur J Clin Pharmacol. 2011;67(7):723–9. doi:10.1007/s00228-010-0983-2.
Ramesh M, Roberts G. Use of night-time benzodiazepines in an elderly inpatient population. J Clin Pharm Ther. 2002;27(2):93–7.
Edwards C, Bushnell JL, Ashton CH, Rawlins MD. Hospital prescribing and usage of hypnotics and anxiolytics. Br J Clin Pharmacol. 1991;31(2):190–2.
Smarter medicine, Choosing Wisely Switzerland. 2016. http://www.smartermedicine.ch/fr/top-5-listen/hospital-care-aim.html. Accessed 17 July 2017.
American Geriatrics Society. Ten things clinicians and patients should question. 2013. http://www.choosingwisely.org/societies/american-geriatrics-society/. Accessed 17 Jul 2017.
Choosing Wisely Canada, five things physicians and patients should question. 2014. http://choosingwiselycanada.org/geriatrics/. Accessed 17 July 2017.
Petrovic M, Spatharakis G, Conroy S, Van Maeles G, Moulias S. Prevalence of sedative drug use in geriatric in-patients: a multi-centre study. Acta Clin Belg. 2006;61(3):119–26. doi:10.1179/acb.2006.019.
Fagnoni P, Limat S, Haffen E, Henon T, Jacquet M, Sechter D, et al. Does hospitalisation affect hypnotic and anxiolytic drug prescribing? Pharm World Sci. 2007;29(6):611–8. doi:10.1007/s11096-007-9097-z.
Pelissolo A, Notides C, Lepine JP, Bisserbe JC. Anxiolytic and hypnotic use by general hospital inpatients: the impact of psychopathology and general medical conditions. Gen Hosp Psychiatry. 1999;21(2):79–86.
Ahmad A, Mast MR, Nijpels G, Elders PJ, Dekker JM, Hugtenburg JG. Identification of drug-related problems of elderly patients discharged from hospital. Patient Prefer Adherence. 2014;8:155–65. doi:10.2147/PPA.S48357.
Pek EA, Remfry A, Pendrith C, Fan-Lun C, Bhatia RS, Soong C. High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults. J Hosp Med. 2017;12(5):310–6. doi:10.12788/jhm.2739.
Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–75. doi:10.1007/s00228-015-1860-9.
Drugs’ database. 2014. http://www.micromedexsolutions.com/micromedex2/librarian/CS/8DF27C/PFActionId/pf.HomePage/ssl/true. Accessed 9 Sept 2017.
Vinks TH, de Koning FH, de Lange TM, Egberts TC. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci. 2006;28(1):33–8. doi:10.1007/s11096-005-4213-4.
GSASA. System for pharmaceutical interventions of the Swiss Association of Public Health Administration and Hospital Pharmacists (GSASA). 2014. http://www.gsasa.ch/pages/activites/prestation-pharmaceutiques/activites-cliniques/?oid=1587&lang=FR. Accessed 9 Sept 2017.
Moller FT, Andersen SE. Benzodiazepines and cyclopyrrolones prior to, during and after hospital admission. Ugeskr Laeger. 2010;172(21):1602–6.
Ballokova A, Peel NM, Fialova D, Scott IA, Gray LC, Hubbard RE. Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study. Drugs Aging. 2014;31(4):299–310. doi:10.1007/s40266-014-0159-3.
Stone KL, Ensrud KE, Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med. 2008;9(Suppl. 1):S18–22. doi:10.1016/S1389-9457(08)70012-1.
Locca JF, Zumbach S, Bula C, Bugnon O. [Management of elderly patients with delirium or dementia in Swiss nursing homes]. Rev Med Suisse. 2007;3(132):2519–20, 22, 24 passim.
Overstall PW, Oldman PN. A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing. 1987;16(1):45–51.
Dehlin O. Hypnotic effect of chlormethiazole in geriatric patients during long-term treatment. Acta Psychiatr Scand Suppl. 1986;329:112–5.
Harenko A. A comparison between chlormethiazole and nitrazepam as hypnotics in psycho-geriatric patients. Curr Med Res. 1974;2(10):657–63.
Pathy MS, Bayer AJ, Stoker MJ. A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. Acta Psychiatr Scand Suppl. 1986;329:99–103.
Von Rohr T RS, Monod S, Büla C, Buclin T, Renard D, et al. Prevalence, incidence and indications of hypno-sedative treatment in hospitalized patients aged 75 and older. CHUV2012 Contract No.: PPH-007.
Schmid VS, Frischer U. Troubles du sommeil. PharmActuel, PharmaSuisse. 2014;06:23–4.
Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010;19(12):1248–55. doi:10.1002/pds.2031.